Safe Re-administration of Tumor Necrosis Factor-alpha (TNFα) Inhibitors in Patients with Rheumatoid Arthritis or Ankylosing Spondylitis Who Developed Active Tuberculosis on Previous Anti-TNFα Therapy

There is no consensus on whether it is safe to re-administer tumor necrosis factor-alpha (TNFα) inhibitors in patients with rheumatoid arthritis (RA) or ankylosing spondylitis (AS) flared after withdrawal of TNFα inhibitors due to active tuberculosis (TB). We evaluated the safety of restarting anti-...

Descripción completa

Detalles Bibliográficos
Autores principales: Suh, Young Sun, Kwok, Seung-ki, Ju, Ji Hyeon, Park, Kyung-Su, Park, Sung-Hwan, Yoon, Chong-Hyeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890474/
https://www.ncbi.nlm.nih.gov/pubmed/24431903
http://dx.doi.org/10.3346/jkms.2014.29.1.38

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890474/
https://www.ncbi.nlm.nih.gov/pubmed/24431903
http://dx.doi.org/10.3346/jkms.2014.29.1.38

Ejemplares similares